- Trade war worries loom over Las Vegas tech show
- America mourns former president Jimmy Carter at state funeral
- Djokovic handed tough Australian Open draw, Sinner faces Jarry test
- Bok prop Nche wary of Dupont threat in Champions Cup
- Conceicao brings good vibes back to AC Milan after Super Cup triumph
- 'We have lost everything': Despair in the Los Angeles fires
- Australia frets over Meta halt to US fact-checking
- Japan startup hopeful ahead of second moon launch
- Ukraine allies to hold last defence meet before Trump takes office
- NBA-best Cavs win 11th in a row to end 15-game Thunder streak
- What you need to know about HMPV
- Venezuela braces for crunch anti-Maduro protests
- Bangladesh garment industry rebounds, but workers say little change
- Asian markets drop as trades fret over US inflation, rates outlook
- Mozambique opposition leader due home amid tension over disputed vote
- Doping and a match made in heaven: Australian Open storylines
- Australia recall McSweeney for Sri Lanka Tests, Connolly set for debut
- Myanmar military adopts anti-junta fighters' drone tactics
- Lebanon set to finally elect president after two-year vacancy
- New twist in US-Cuba trademark fight over Havana Club rum
- CES tech looks to help world's aging population
- Venezuela repression increases ahead of crunch anti-Maduro protests
- Rubber tappers forge sustainable future in Amazon
- 'No more fires,' demand fed-up Amazon residents
- Assault on Chad presidential complex leaves 19 dead
- Crowds throng as Jesus statue parades through Philippine capital
- Slot fumes after Spurs teenager Bergvall avoids red card to sink Liverpool
- Fighting at Chad presidency leaves 19 dead, several injured
- US astronauts upbeat seven months into eight-day mission
- Bergvall strikes as Spurs snatch League Cup semi-final lead over Liverpool
- Extreme weather, suburban sprawl fuel LA's wildfires
- Campaigners fear spike in hate speech as Meta lifts restrictions
- Yakuza leader pleads guilty in US court to conspiring to sell nuclear material
- Barcelona defeat Bilbao without Olmo to reach Spanish Super Cup final
- Displaced LA residents in shock at scale of fire destruction
- Gunfire erupts inside presidency in Chad capital
- Miami and Tampa to host outdoor NHL contests in 2026
- Popov claims first World Cup win in Madonna di Campiglio slalom
- Tottenham star Bentancur 'conscious' after head injury in Liverpool clash
- NHL Kings postpone game while NFL monitors LA area wildfires
- Barcelona defeat Athletic without Olmo to reach Spanish Super Cup final
- Bulgaria's Popov claims first World Cup win in Madonna di Campiglio slalom
- Niemann and Nicolai Hojgaard accept special Masters invitations
- Political chess or true beliefs? Zuckerberg's surprise Trump pivot
- Hosszu, swimming's 'Iron Lady', retires at 35
- US withholds $3.6 mln payment to WADA after no audit
- Venezuela opposition decry crackdown before Maduro swearing-in
- US Fed officials concerned over 'stalled' disinflation, tariffs: minutes
- Whole streets burn as fires rage around Los Angeles
- Celebrities flee Los Angeles fires as Hollywood events scrapped
Moderna rebuked over plan to hike Covid vaccine to $130
Moderna's chief executive on Wednesday defended the US company's plan to quadruple the price of its lifesaving Covid vaccine to as much as $130 per dose as soon as government stockpiles run out.
Democratic Senator Bernie Sanders lashed out at the price hike, denouncing the "unprecedented level of corporate greed" in the pharmaceutical industry. "And that is certainly true with Moderna," Sanders said.
Moderna has so far charged between about $15 and $26 for doses of its vaccine, according to the Kaiser Family Foundation.
The US government subsidized $1.7 billion of Moderna's research at the start of the pandemic and then purchased $10 billion worth of vaccine, Sanders said at a Senate hearing where the company's CEO Stephane Bancel was testifying.
Sanders said Moderna was "thanking the taxpayers of the United States" by more than quadrupling the vaccine's price "at a time when it costs less than $3 to manufacture."
Sanders noted several times at the hearing that Moderna conducted buybacks of its own stock and paid its own executives at its Cambridge, Massachusetts, headquarters handsomely.
Bancel defended Moderna, saying the distribution system will change completely when the US government lifts a state of health emergency, perhaps as soon as May.
Up until now, Moderna had only one customer, distributed its vaccine to only a few warehouses and did not have to pay for the cost of expired doses.
By switching to a more traditional marketing approach, "we're going to have 10,000 customers" and have to "manage to deliver to 60,000 pharmacies, doctors' offices and hospitals," he added.
Currently distributed in multidose vials, the vaccine will be sold mostly in single-dose vials or directly in prefilled syringes. And Moderna will have to take care of the unsold doses.
The company expects a "90 percent reduction in demand," Bancel said. "We are losing economies of scale. We must assume the wastage risk and cost that the US government used to assume."
Moderna also pledged to set up a program so that the uninsured or underinsured would not have to pay anything.
When pressed by Sanders about the possibility of the company lowering its price for government-run health insurance programs, Bancel said discussions were underway with all customers.
P.Martin--AMWN